INTRODUCTION
============

Protein lysine acetylation is one of the most important post-translational modifications; it plays important roles in protein stability, gene expression regulation, protein--protein interactions (PPI) and cellular metabolism ([@gks437-B1; @gks437-B2; @gks437-B3; @gks437-B4]). Acetylation was first discovered in histones ([@gks437-B5]) and subsequently, in non-histone proteins ([@gks437-B6]). The number of acetylated proteins is rapidly increasing because of the development of high-throughput technologies, such as immune-precipitation combined mass spectrometric analysis ([@gks437-B7]). Over 2000 human acetylated proteins (4000 lysine sites) have been identified via traditional experimental methods and large-scale mass spectrometric analysis ([@gks437-B8]). However, determining which lysine (K)-acetyl-transferases (KATs) are responsible for the acetylation of given proteins remains difficult.

Similar to kinases that catalyze the phosphorylation of a specific subset of substrates, KATs are substrate-specific enzymes. Over 20 human KATs have been identified ([@gks437-B9]). Although categorizing all of these KATs remains difficult due to their variety, nine KATs have been divided into three families based on sequence and structural similarity ([@gks437-B10]). The families include CBP/p300, GCN5/PCAF and MYST. Each of the three families catalyzes a special subgroup of substrates. For instance, WRN is acetylated by CBP/p300, but not by PCAF or TIP60 ([@gks437-B11]). Although different KAT families can target the same protein, they possibly acetylate different lysine sites. For instance, PCAF acetylates p53 at site K320 ([@gks437-B12]), whereas TIP60 acetylates the same protein at K120 ([@gks437-B13]). Thus, the construction of *in silico* tools for the prediction of KAT-specific acetylation sites is reasonable.

Previous *in silico* prediction methods have focused on acetylation itself. For example, several research groups have predicted acetylation using the support vector machine (SVM) method. Such methods can classify new sequences by learning the features of sequence contexts surrounding the acetylated lysines ([@gks437-B14; @gks437-B15; @gks437-B16]). Aside from SVM, other methods, such as meta-analysis and sequence clustering, have also been used to predict acetylation sites ([@gks437-B17],[@gks437-B18]). However, these tools can only provide information on the probability of acetylation for a given protein, but cannot provide KAT-specific acetylation prediction.

In this study, we constructed a KAT-specific prediction server called acetylation set enrichment based (ASEB), which can predict not only the acetylation state, but also the responsible KAT family. The prediction method was initially established based on the sequence similarity principle. Detailed algorithms were presented in our previous study ([@gks437-B8]). In this article, we further integrated protein--protein interaction information to enhance prediction accuracy. A graph of the rank of the predicted *P*-value from the background *P*-values was also provided, which would enable users to evaluate the predicted results. We also evaluated the sensitivity and specificity of ASEB on a new independent data set, which proves that the web server could work for other species besides humans. We take the human protein TP53 as an example to illustrate the utility of the ASEB server.

WEB SERVER CONSTRUCT
====================

The ASEB web server takes advantage of Asynchronous JavaScript and XML technology, which can dynamically display the status of the predicting process. The web site follows HTML 4.01 Strict and CSS version 2.1 standards to maintain consistency across different browsers. Compared with the method in the original study ([@gks437-B8]), the web server was improved in three areas as follows. (i) The enzyme often interacts with its substrates directly or indirectly through scaffold proteins to achieve a reaction. PPI information is helpful in predicting enzyme-mediated biological reactions; as such, the shortest path between KAT and query protein in the protein--protein interaction network was added to enhance the accuracy of prediction. (ii) Suggestions on cut-off selection may be useful for users of the web server; thus, we graphed the rank of the predicted *P*-value from the background *P*-values, which would enable users to evaluate predicted results. (iii) Although the web server was constructed based on human proteins, it can also be used to predict acetylated proteins from other species due to the evolutional conservation of acetylated proteins and KATs. Acetylation data from other species were further added and the performance on this data was evaluated, revealing that the web server could also work on these species.

Shortest path between KAT and query protein
-------------------------------------------

In the acetylation process, the enzyme interacts with its substrates directly or indirectly. We could hypothesize that if KATs acetylate the query protein; they should interact directly or at least be mediated by the scaffold proteins. Research has shown that PPI information can enhance the accuracy of protein kinase substrate prediction ([@gks437-B19]). In this article, we provided the shortest path between KAT and the query protein in the PPI network. The prediction results should be more reliable when the KAT and the query protein interact. The shortest path between the query protein and a KAT was calculated via Dijkstra\'s algorithm. During the determination of the shortest path, the values of the edges in the PPI network were estimated via the following two methods: (i) the values of the edges were assigned as one for the PPI edges obtained from the database PINA ([@gks437-B20]) and (ii) the value of the edge between 'protein1' and 'protein2' was assigned as 'log(1000 − combinedScore(protein1, protein2))' for the PPI edges obtained from the database STRING ([@gks437-B21]). The combined scores between proteins were queried from the database STRING. The service of shortest path in the PPI network between the KAT and the query protein is currently limited to 'Homo sapiens' proteins.

Cut-off selection
-----------------

With ASEB, each query lysine site can get a *P*-value. A lower *P*-value indicates a higher probability of the acetylation of the lysine site by the selected KAT family. Furthermore, each *P*-value\'s rank in the background *P*-values was generated. The background *P*-values were calculated from all lysine sites on human proteins and then ranked from lowest to highest. Once a *P*-value is given, its rank in the background can be determined, which would be useful for users to evaluate predicted results. To control the false-positive predictions, we suggest users pay more attention to the lysine sites with *P*-values lower than the top 10%; in this case, the estimated specificity will be higher than 90%. Lysine sites passing the suggested cut-off are highlighted by color in the table of prediction results on the web site. The background set (all lysine sites on human proteins) should contain unreported acetylation sites; as such, the specificity is very likely underestimated. In our opinion, this cut-off should be loosened once interaction between KAT and query protein occurs. In applications, users can adjust the cut-off values according to the trade-off between discovering more putative acetylation sites and making fewer false-positive predictions.

Evaluation on new independent data set
--------------------------------------

In our previous study, we initially ran a leave-one-out method to estimate the sensitivity for known acetylated sites and perform the ASEB method on 1000 randomly selected lysine sites to estimate specificity. The detailed results are available on the web server. We also predicted the acetylation states of proteins without known KATs and experimentally validated the prediction results. In this study, we further tested the method on a new independent data set from other species. This data set contains 42 and 30 known acetylation sites from other species, which are acetylated by the orthologs of CBP/p300 and GCN5/PCAF. All these data can be accessed from the web server. A total of 1000 lysine sites were randomly selected from other species as a background data set. The test results indicated that the ASEB method performed similarly well on other species; the detailed results can be found in [Table 1](#gks437-T1){ref-type="table"}. Given that this background test set might still contain unreported acetylation sites, the specificity estimated with this test set might be underestimated. Table 1.Validation resultsKAT FamilyCBP/p300GCN5/PCAFKnown (Sensitivity)Background (Specificity)Known (Sensitivity)Background (Specificity)Total peptides421000301000*P* ≤ 1e^−4^4 (9.5%)18 (98.2%)8 (26.7%)4 (99.6%)*P* ≤ 1e^−3^8 (19.0%)32 (96.8%)13 (43.3%)9 (99.1%)*P* ≤ 1e^−2^11 (26.2%)77 (92.3%)16 (53.3%)35 (96.5%)*P* ≤ 1e^−1^25 (59.5%)181 (81.9%)20 (66.7%)137 (86.3%)

Input
-----

To predict whether lysine sites within a given protein sequence can be acetylated by specific KAT families, users should initially select the KAT family that interests them. The query protein sequence can then be directly input into the 'Sequences' text box. Other input terms, such as Swiss-Prot accession number or protein name, are also permitted but are limited to 'Homo sapiens'. If the accession number or protein name is available, users can click the 'Load Sequence' button to obtain the protein sequence instead of using manual input. When users predict acetylation sites on protein sequences from other species, the predicted KATs should be correspondingly translated into KATs in their own species. For example, a sequence from yeast predicted to be acetylated by the GCN5/PCAF family should be translated as acetylated by the yGcn5 protein, instead of by the human GCN5 or PCAF protein. Aside from the prediction of the acetylation state based on the sequence, the interaction network between KATs and the query protein can also be generated by entering the protein accession number or name.

On the prediction page, the web server takes the TP53 with a Swiss-Prot accession number P04637 as an input example. An 'Example' button is provided to load this protein. If users click this button, the accession number for TP53 will be entered automatically. If users subsequently click the 'Load Sequence' button, the protein sequence would appear in the 'Sequences' text box.

Output
------

The outputs include the prediction results for each lysine site and the PPI interaction networks between the query protein and the KATs ([Figure 1](#gks437-F1){ref-type="fig"}). The prediction results are shown in a table containing four columns: the selected KAT family, the lysine position, the 17 length peptides surrounding the lysine and the ASEB *P*-values ([Figure 1](#gks437-F1){ref-type="fig"}A). The range of the *P*-value is from 0.0001 to 1, with an interval of 0.0001. For details on the algorithm, refer ([@gks437-B8]). If users click on a *P*-value, a plot will appear and show the rank of the *P*-value from the background *P*-values for all lysine sites on human proteins ([Figure 1](#gks437-F1){ref-type="fig"}B). Lysine sites with *P*-values ranked in the top 10% are highlighted by color in the table of prediction results ([Figure 1](#gks437-F1){ref-type="fig"}A). Figure 1.Prediction results for human protein TP53. (**A**) Table containing predicted *P*-values for each lysine site on TP53. The sites with lower *P*-values in the top 10% were highlighted by background color. (**B**) Plot showing the rank of *P*-value 0.04 from the background. The *X*-axis indicates the *P*-value, and the *Y*-axis indicates the rank of this *P*-value. (**C**) Shortest path between the lysine-acetyl-transferase (CREBBP) and the query protein (TP53). (**D**) Example of the PPI network view. The shortest path between the lysine-acetyl-transferase (CREBBP) and the query protein (TP53) is highlighted by the bold black line.

When users provide a Swiss-Prot accession number or protein name, the PPI interaction networks will be presented. Various paths exist from the KATs to the input proteins, and the shortest of these was extracted to represent the relationship between the interacting proteins. These networks were derived from two main PPI databases, PINA and STRING ([@gks437-B20],[@gks437-B21]). For example, when we selected the CBP/p300 family and submitted the accession number for TP53, we obtained the shortest path between the CBP or p300 and the TP53 in the PPI network ([Figure 1](#gks437-F1){ref-type="fig"}C). Both CBP and p300 directly interact with TP53. By clicking the network view link, users can visualize the interaction between CBP or p300 and TP53 ([Figure 1](#gks437-F1){ref-type="fig"}D). The shortest path from the KAT to the query protein is highlighted by a bold black line. A step-by-step tutorial page with detailed explanation can be accessed on the web server.

Other services provided by the ASEB web server
----------------------------------------------

In addition to KAT-specific acetylation prediction, users can also search for the identified acetylation proteins and sites that have been collected. Search results include acetylated lysine sites on query proteins, KATs responsible for the lysine sites (if present), and the PubMed ID for original papers describing the corresponding acetylation. These data can also be downloaded directly. A template program in Perl was also provided to allow users to access the services programmatically, rather than through manual interaction. Users who are familiar with R can download the ASEB R package (developing version) from Bioconductor. The R package can process a large number of proteins simultaneously. The instructions for use are included in the package.

CONCLUSION
==========

ASEB is a web server for KAT-specific acetylation prediction that is available for free. The efficacy of ASEB is validated via independent methods, including biological experiments. To our knowledge, ASEB is the first KAT-specific acetylation prediction method. Although the present version only predicts acetylation catalyzed by two KAT families, it is helpful for scientists in the acetylation field. We will continue to collect experimentally identified acetylation sites and responsible KATs. We will update the web server when the number of newly detected acetylation sites is adequate to enhance efficiency, and when data from other KAT families can provide reliable predicted results.
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